Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 2.868
Filtrar
1.
J Infect Dev Ctries ; 18(6): 919-924, 2024 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-38990994

RESUMEN

OBJECTIVE: To compare the short and long-term benefits (the length of hospital stay, surgical complications, and early clinical improvement) of adding early ultrasound-guided drainage to broad-spectrum antibiotic treatment. METHODOLOGY: Patients undergoing tubo-ovarian abscess treatment between January 2017 and June 2022 in a tertiary hospital were retrospectively evaluated. Of the patients studied, 50 subjects were treated with antibiotics alone and 63 underwent guided drainage. Twenty-one individuals underwent early drainage within 72 hours of admission, and 42 underwent guided drainage after this period. RESULTS: There was no statistical difference in the length of hospital stay between the groups simultaneously, averaging 6.4 days for the controls, 5.1 days for the early drainage group, and 9.6 days for the late drainage group (p = 0.290). In the multiple linear regression with the length of hospital stay outcome and adjusting for potential confounding factors, there was an average reduction of 2.9 days in the hospital stay (p = 0.04) for the early drainage group (< 72 hours) compared to the controls. Early clinical improvement and an expected drop in CRP were more frequent in patients who underwent drainage. Length of hospital stay increases with abscess diameter: 0.4 [(95% CI 0.1 - 0.7) (p = 0.05)] days per centimeter, regardless of other variables. CONCLUSIONS: Ultrasound-guided drainage of tubo-ovarian abscesses associated with antibiotic therapy is an effective treatment, with few complications, and may lead to clinical improvement especially when performed early.


Asunto(s)
Absceso , Antibacterianos , Drenaje , Tiempo de Internación , Enfermedades del Ovario , Humanos , Femenino , Estudios Retrospectivos , Drenaje/métodos , Adulto , Estudios Transversales , Absceso/terapia , Absceso/diagnóstico por imagen , Absceso/cirugía , Absceso/tratamiento farmacológico , Antibacterianos/uso terapéutico , Enfermedades del Ovario/terapia , Enfermedades del Ovario/diagnóstico por imagen , Enfermedades del Ovario/tratamiento farmacológico , Enfermedades del Ovario/cirugía , Persona de Mediana Edad , Tratamiento Conservador/métodos , Enfermedades de las Trompas Uterinas/terapia , Enfermedades de las Trompas Uterinas/diagnóstico por imagen , Enfermedades de las Trompas Uterinas/cirugía , Ultrasonografía Intervencional/métodos , Resultado del Tratamiento , Ultrasonografía
3.
BMC Infect Dis ; 24(1): 697, 2024 Jul 14.
Artículo en Inglés | MEDLINE | ID: mdl-39004725

RESUMEN

BACKGROUND: This case report presents a unique instance of abscesses with an uncommon pathogen isolated from blood cultures. CASE PRESENTATION: We present the case of a perianal abscess in a 50-year-old man with a history of cocaine abuse and bilateral hip replacements. The rapid progression led to septic shock and multi-organ failure, requiring intensive care unit admission, surgery including protective transversostomy. Blood cultures showed growth of Butyricimonas spp. with resistance to penicillin and piperacillin-tazobactam. The immediate switch to meropenem led to a significant improvement in the patient's condition. The patient was discharged after 40 days of hospitalization in good general condition and the reversal of the transversostomy was performed six months later. CONCLUSION: The identification of Butyricimonas faecihominis, a rarely reported pathogen, emphasizes the challenges of diagnosing and treating unusual infections. This case emphasizes the importance of rapid microbiological diagnosis, interdisciplinary collaboration, and targeted antibiotic therapy in the treatment of abscesses and sepsis.


Asunto(s)
Absceso , Antibacterianos , Humanos , Masculino , Persona de Mediana Edad , Absceso/microbiología , Absceso/tratamiento farmacológico , Antibacterianos/uso terapéutico , Antibacterianos/farmacología , Meropenem/uso terapéutico
4.
Head Face Med ; 20(1): 38, 2024 Jul 12.
Artículo en Inglés | MEDLINE | ID: mdl-38997761

RESUMEN

BACKGROUND: A parotid abscess (PA) is a complication of an acute bacterial parotitis with a potentially life-threatening course. To date, data on the diagnosis and therapy of PA is sparse and mostly consists of case reports or case series. Therefore, this study aimed at comprehensively analyzing the microbiological spectrum and the therapeutic management in a bi-institutional setting. METHODS: A retrospective clinical chart review was performed to identify all patients surgically treated for PA at two tertiary care centers in Germany. Data on demographics, clinical management and microbiological data including species identification, pathogenicity, type of antibiotic therapy, adjustment of antibiotics, antibiotic sensitivity testing, and smear test results were extracted. Intervention-related variables and etiology were analyzed for their statistical association with outcome variables. RESULTS: Overall, 85 patients were included. Most patients (92.9%) underwent surgical incision. Around half of the patients (45.9%) were treated under local anesthesia. No facial nerve palsy was observed. The most frequently detected pathogens were Streptococci (n = 23), followed by Staphylococcus aureus (n = 6) including one case of methicillin-resistant Staphylococcus aureus. Most patients (68.2%) received an aminopenicillin ± beta-lactamase inhibitor as empiric antibiotic therapy. In 6 cases the antibiotic therapy was modified after receiving the antibiogram. Four patients (5.2%) presented with recurrent PA. Etiology was idiopathic (42.4%), followed by tumorous (12.9%), obstructive, and immunosuppressive (each 11.8%). Patients with a dental focus (p = 0.007) had a longer duration of hospitalization. CONCLUSION: The results show that the surgical therapy of PA under local anesthesia is safe. A dental examination should routinely be performed to rule out a dental focus. Obtaining a microbiological specimen in order to modify antibiotic therapy if necessary and a histopathological specimen to rule out a tumorous etiology is obligate.


Asunto(s)
Absceso , Antibacterianos , Humanos , Masculino , Estudios Retrospectivos , Femenino , Absceso/microbiología , Absceso/terapia , Absceso/cirugía , Absceso/tratamiento farmacológico , Persona de Mediana Edad , Antibacterianos/uso terapéutico , Adulto , Anciano , Alemania , Parotiditis/microbiología , Parotiditis/tratamiento farmacológico , Parotiditis/cirugía , Parotiditis/terapia , Enfermedades de las Parótidas/microbiología , Enfermedades de las Parótidas/cirugía , Enfermedades de las Parótidas/tratamiento farmacológico , Pruebas de Sensibilidad Microbiana , Adulto Joven , Anciano de 80 o más Años , Resultado del Tratamiento , Adolescente
5.
Iowa Orthop J ; 44(1): 17-22, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38919358

RESUMEN

Background: A case of chronic osteomyelitis with Brodie's abscess of the cuboid caused by a wooden foreign body penetrating the plantar foot. Total cuboidectomy was carried out with implantation of an anatomically molded antibiotic-impregnated cement spacer with culture-specific postoperative intravenous antibiotics. At six months of follow-up, the patient was completely asymptomatic without evidence of a recurrence of infection. Final radiographs also didn't show spacer migration or surrounding bone erosions. The spacer obviated the need for any foot fusion which preserved foot biomechanics. The patient didn't need to use any braces or insoles. Conclusion: Osteomyelitis should always be on the differential list of lytic lesions of the tarsal bones, especially if there is a history of prior foot trauma. In this case, cuboid excision and placement of an antibiotic-impregnated cement spacer provided sustained relief of symptoms without evidence of recurrence or complications for six months.Level of Evidence: V.


Asunto(s)
Antibacterianos , Cementos para Huesos , Osteomielitis , Huesos Tarsianos , Humanos , Osteomielitis/tratamiento farmacológico , Osteomielitis/cirugía , Antibacterianos/uso terapéutico , Antibacterianos/administración & dosificación , Cementos para Huesos/uso terapéutico , Huesos Tarsianos/cirugía , Huesos Tarsianos/diagnóstico por imagen , Masculino , Resultado del Tratamiento , Absceso/cirugía , Absceso/diagnóstico por imagen , Absceso/tratamiento farmacológico , Cuerpos Extraños/cirugía , Cuerpos Extraños/diagnóstico por imagen , Adulto
6.
Front Cell Infect Microbiol ; 14: 1352339, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38808066

RESUMEN

Antibiotic drug combination therapy is critical for the successful treatment of infections caused by multidrug resistant pathogens. We investigated the efficacy of ß-lactam and ß-lactam/ß-lactamase inhibitor combinations with other antibiotics, against the hypervirulent, ceftazidime/avibactam resistant Pseudomonas aeruginosa Liverpool epidemic strain (LES) B58. Although minimum inhibitory concentrations in vitro differed by up to eighty-fold between standard and host-mimicking media, combinatorial effects only marginally changed between conditions for some combinations. Effective combinations in vitro were further tested in a chronic, high-density murine infection model. Colistin and azithromycin demonstrated combinatorial effects with ceftazidime and ceftazidime/avibactam both in vitro and in vivo. Conversely, while tobramycin and tigecycline exhibited strong synergy in vitro, this effect was not observed in vivo. Our approach of using host-mimicking conditions and a sophisticated animal model to evaluate drug synergy against bacterial pathogens represents a promising approach. This methodology may offer insights into the prediction of combination therapy outcomes and the identification of potential treatment failures.


Asunto(s)
Absceso , Antibacterianos , Modelos Animales de Enfermedad , Sinergismo Farmacológico , Quimioterapia Combinada , Pruebas de Sensibilidad Microbiana , Infecciones por Pseudomonas , Pseudomonas aeruginosa , Animales , Pseudomonas aeruginosa/efectos de los fármacos , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Infecciones por Pseudomonas/tratamiento farmacológico , Infecciones por Pseudomonas/microbiología , Ratones , Absceso/tratamiento farmacológico , Absceso/microbiología , Combinación de Medicamentos , Farmacorresistencia Bacteriana Múltiple , Femenino , Ceftazidima/farmacología , Ceftazidima/uso terapéutico , Azitromicina/farmacología , Azitromicina/uso terapéutico , Azitromicina/administración & dosificación , Compuestos de Azabiciclo/farmacología , Compuestos de Azabiciclo/uso terapéutico , Colistina/farmacología , Colistina/uso terapéutico , Colistina/administración & dosificación
7.
J Antimicrob Chemother ; 79(7): 1668-1672, 2024 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-38785349

RESUMEN

BACKGROUND: Invasive fungal infections (IFIs) are severe and difficult-to-treat infections affecting immunocompromised patients. Antifungal drug penetration at the site of infection is critical for outcome and may be difficult to achieve. Data about antifungal drug distribution in infected human tissues under real circumstances of IFI are scarce. METHODS: Multiple samples were obtained from soft tissue abscesses of a lung transplant patient with Candida albicans invasive candidiasis who underwent recurrent procedures of drainage, while receiving different consecutive courses of antifungal therapy [itraconazole (ITC), fluconazole, caspofungin]. Antifungal drug concentrations were measured simultaneously at the site of infection (surrounding inflammatory tissue and fluid content of the abscess) and in plasma for calculation of the tissue/plasma ratio (R). The concentration within the infected tissue was interpreted as appropriate if it was equal or superior to the MIC of the causal pathogen. RESULTS: A total of 30 tissue samples were collected for measurements of ITC (n = 12), fluconazole (n = 17) and caspofungin (n = 1). Variable concentrations were observed in the surrounding tissue of the lesions with median R of 2.79 (range 0.51-15.9) for ITC and 0.94 (0.21-1.37) for fluconazole. Concentrations ranges within the fluid content of the abscesses were 0.39-1.83 for ITC, 0.66-1.02 for fluconazole and 0.23 (single value) for caspofungin. The pharmacodynamic target (tissue concentration ≥ MIC) was achieved in all samples for all three antifungal drugs. CONCLUSIONS: This unique dataset of antifungal drug penetration in infected human soft tissue abscesses suggests that ITC, fluconazole and caspofungin could achieve appropriate concentrations in soft tissue abscesses.


Asunto(s)
Absceso , Antifúngicos , Caspofungina , Infecciones de los Tejidos Blandos , Humanos , Antifúngicos/farmacocinética , Antifúngicos/uso terapéutico , Antifúngicos/administración & dosificación , Absceso/tratamiento farmacológico , Absceso/microbiología , Caspofungina/farmacocinética , Caspofungina/uso terapéutico , Infecciones de los Tejidos Blandos/tratamiento farmacológico , Infecciones de los Tejidos Blandos/microbiología , Fluconazol/farmacocinética , Fluconazol/uso terapéutico , Fluconazol/administración & dosificación , Candida albicans/efectos de los fármacos , Candidiasis Invasiva/tratamiento farmacológico , Candidiasis Invasiva/microbiología , Pruebas de Sensibilidad Microbiana , Masculino , Itraconazol/farmacocinética , Itraconazol/uso terapéutico , Itraconazol/administración & dosificación , Persona de Mediana Edad , Femenino , Adulto
8.
Front Cell Infect Microbiol ; 14: 1361326, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38572322

RESUMEN

Spinal tuberculosis is a common extrapulmonary type that is often secondary to pulmonary or systemic infections. Mycobacterium tuberculosis infection often leads to the balance of immune control and bacterial persistence. In this study, 64 patients were enrolled and the clinicopathological and immunological characteristics of different age groups were analyzed. Anatomically, spinal tuberculosis in each group mostly occurred in the thoracic and lumbar vertebrae. Imaging before preoperative anti-tuberculosis therapy showed that the proportion of abscesses in the older group was significantly lower than that in the younger and middle-aged groups. However, pathological examination of surgical specimens showed that the proportion of abscesses in the older group was significantly higher than that in the other groups, and there was no difference in the granulomatous inflammation, caseous necrosis, inflammatory necrosis, acute inflammation, exudation, granulation tissue formation, and fibrous tissue hyperplasia. B cell number was significantly lower in the middle-aged and older groups compared to the younger group, while the number of T cells, CD4+ T cells, CD8+ T cells, macrophages, lymphocytes, plasma cells, and NK cells did not differ. Meaningfully, we found that the proportion of IL-10 high expression and TGF-ß1 positive in the older group was significantly higher than that in the younger group. TNF-α, CD66b, IFN-γ, and IL-6 expressions were not different among the three groups. In conclusion, there are some differences in imaging, pathological, and immune features of spinal tuberculosis in different age groups. The high expression of IL-10 and TGF-ß1 in older patients may weaken their anti-tuberculosis immunity and treatment effectiveness.


Asunto(s)
Mycobacterium tuberculosis , Tuberculosis de la Columna Vertebral , Persona de Mediana Edad , Humanos , Anciano , Interleucina-10/metabolismo , Factor de Crecimiento Transformador beta1/metabolismo , Tuberculosis de la Columna Vertebral/tratamiento farmacológico , Tuberculosis de la Columna Vertebral/metabolismo , Linfocitos T CD8-positivos/metabolismo , Absceso/tratamiento farmacológico , Absceso/metabolismo , Antituberculosos/uso terapéutico , Necrosis/tratamiento farmacológico , Necrosis/metabolismo , Linfocitos T CD4-Positivos , Citocinas/metabolismo
9.
Front Cell Infect Microbiol ; 14: 1367111, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38606296

RESUMEN

Introduction: Klebsiella pneumoniae can cause a wide range of infections. Hypervirulent K. pneumoniae (hvKp), particularly associated with the K1 and K2 capsular types, is an increasingly significant microorganism with the potential to cause invasive infections, including renal abscesses. Despite the rising prevalence of hvKp infections, information on renal abscesses caused by K. pneumoniae is limited, and the clinical significance of hvKp associated with specific virulence genes remains elusive. Methods: This study performed at a 1200-bed tertiary hospital sought to identify the clinical and microbiological characteristics of renal abscesses caused by K. pneumoniae, focusing on various virulence genes, including capsular serotypes and multilocus sequence typing (MLST). Results: Over an 8-year period, 64 patients with suspected renal abscesses were reviewed. Ten patients diagnosed with K. pneumoniae-related renal abscesses were ultimately enrolled in the study. Among the isolates from the 10 patients, capsular serotype K2 was predominant (40.0%), followed by K1 (30.0%). The most common sequence type by MLST was 23 (40.0%). In particular, six patients (60.0%) harbored specific genes indicative of hvKp: iucA, peg-344, rmpA, and rmpA2. Conclusions: Our findings highlight the importance of hvKp as a pathogen in renal abscesses. Although the nature of hvKp is relatively unknown, it is widely recognized as a highly virulent pathogen that can infect relatively healthy individuals of various ages and simultaneously cause infections at multiple anatomical sites. Therefore, when treating patients with K. pneumoniae-related renal abscesses, caution is necessary when considering the characteristics of hvKp, such as potential bacteremia, multi-organ abscess formation, and metastatic spread.


Asunto(s)
Infecciones por Klebsiella , Infecciones Urinarias , Humanos , Virulencia/genética , Klebsiella pneumoniae , Absceso/complicaciones , Absceso/tratamiento farmacológico , Tipificación de Secuencias Multilocus , Relevancia Clínica , Antibacterianos/uso terapéutico , Infecciones Urinarias/complicaciones , Infecciones por Klebsiella/microbiología
10.
Int Breastfeed J ; 19(1): 27, 2024 Apr 19.
Artículo en Inglés | MEDLINE | ID: mdl-38641819

RESUMEN

BACKGROUND: Lactational mastitis is a common painful and debilitating inflammation of breast tissue, generally treated conservatively or with pus puncture in case of breast abscess. However, treating mastitis in patients with implantable surgical material located in the affected breast region can be extremely challenging. We present an unusual case of lactational mastitis complicated by pacemaker pocket infection in a breastfeeding mother. CASE PRESENTATION: A 35-year-old pacemaker-dependent female developed lactational mastitis seven weeks postpartum. Initially, the condition was treated conservatively with analgesics and antibiotics. After abscess formation, pus was aspirated using fine-needle aspiration technique. Four weeks after mastitis resolution, pacemaker pocket infection developed. According to current cardiovascular implantable electronic device infection treatment guidelines a complete surgical extraction of the entire electronic system, followed by targeted antibiotic treatment and reimplantation of a new device after infection resolution, was recommended. However, after thorough discussion with the young woman and her family and after detailed review of surgery-related risks, she declined a potentially high-risk surgical procedure. Thus, only the pulse generator was explanted; pacing leads positioned in the sub-pectoral pocket; new pacemaker implanted on the contralateral side and broad-spectrum antibiotic therapy continued for six weeks. After breastfeeding cessation, and with chronic fistula development at the primary pacemaker implantation site, the possibility of delayed surgical intervention including complete extraction of retained pacemaker leads was again thoroughly discussed with her. After thoughtful consideration the woman consented to the proposed treatment strategy. A surgical procedure including transvenous lead extraction through the primary implantation venous entry site, using hand-powered bidirectional rotational sheaths, was successfully performed, removing all retained leads through the left subclavian venous entry site, and leaving the fully functional and clinically uninfected pacemaker on the contralateral site intact. CONCLUSION: Although patients' decisions for delayed extraction in a case of cardiovascular implantable electronic device infection should be discouraged by attending physicians and members of interdisciplinary teams, our case shows that a stepwise treatment strategy may be successful as a bailout clinical scenario in patients with specific requests, demands and / or clinical needs.


Asunto(s)
Mastitis , Marcapaso Artificial , Humanos , Femenino , Adulto , Lactancia Materna , Absceso/tratamiento farmacológico , Mastitis/terapia , Marcapaso Artificial/efectos adversos , Lactancia , Antibacterianos/uso terapéutico
11.
Indian J Med Microbiol ; 49: 100600, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38685381

RESUMEN

Chest wall tuberculosis is a very rare clinical entity that accounts for 1-5% of musculoskeletal tuberculosis (TB). Here we present a case of chest wall TB. A 16-year-old boy presented with complaints of progressive increasing swelling over the right hemithorax following a history of trauma. Radiologically it was a localized liquid collection with no connection to the thoracic cavity. Pus sample was sent to the mycobacteriology laboratory. The Gene Xpert result came as positive, and sensitive to rifampicin while the acid-fast bacilli (AFB) smear test was negative. Diagnosing a case of chest wall TB is always challenging for clinicians.


Asunto(s)
Absceso , Pared Torácica , Humanos , Masculino , Pared Torácica/microbiología , Pared Torácica/patología , Adolescente , Absceso/microbiología , Absceso/diagnóstico , Absceso/tratamiento farmacológico , Tuberculosis/diagnóstico , Tuberculosis/microbiología , Tuberculosis/tratamiento farmacológico , Mycobacterium tuberculosis/aislamiento & purificación , Mycobacterium tuberculosis/genética , Antituberculosos/uso terapéutico , Rifampin/uso terapéutico
12.
Transpl Infect Dis ; 26(3): e14278, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38584595

RESUMEN

A renal allograft abscess is a relatively rare condition. Appropriate antimicrobial therapy and drainage are recommended for treating renal abscesses. However, drainage can be challenging, depending on the location of the abscess. We present the case of a young female kidney transplant recipient who was successfully cured of a renal allograft abscess, using antimicrobial agents and appropriate follow-up imaging, without the need of any risky procedures.


Asunto(s)
Absceso , Aloinjertos , Trasplante de Riñón , Humanos , Trasplante de Riñón/efectos adversos , Femenino , Absceso/tratamiento farmacológico , Absceso/microbiología , Absceso/diagnóstico por imagen , Absceso/cirugía , Adulto , Antibacterianos/uso terapéutico , Drenaje , Resultado del Tratamiento , Antiinfecciosos/uso terapéutico
14.
BMJ Case Rep ; 17(4)2024 Apr 29.
Artículo en Inglés | MEDLINE | ID: mdl-38684354

RESUMEN

Varicella is the manifestation of primary infection with the varicella-zoster virus, mainly affecting preschool and school-aged children. The children suffer from a generalised, vesicular rash and fever. Despite the infection's typically non-threatening course, a variety of severe complications have been described.The authors present the case of a female infant suffering from varicella and developing preseptal cellulitis with a frontal abscess while being treated with intravenous antibiotics. Otorhinolaryngology consultation was sought since the clinical image was highly suggestive for sinusitis complications, namely orbital cellulitis and frontal bone osteomyelitis (Pott's puffy tumour). However, the child was below the age of frontal sinus development and there was no other apparent sign of sinonasal involvement. Ultrasonography revealed a mid-frontal collection without signs of abscess formation preseptally or postseptally, leading to the diagnosis of cutaneous superinfection of varicella lesions. The frontal abscess was drained, and the child fully recovered under antibiotic treatment.


Asunto(s)
Absceso , Antibacterianos , Varicela , Humanos , Femenino , Lactante , Varicela/complicaciones , Varicela/diagnóstico , Diagnóstico Diferencial , Antibacterianos/uso terapéutico , Absceso/diagnóstico , Absceso/diagnóstico por imagen , Absceso/tratamiento farmacológico , Sinusitis/tratamiento farmacológico , Sinusitis/diagnóstico , Sinusitis/complicaciones , Rinitis/diagnóstico , Rinitis/tratamiento farmacológico , Enfermedad Aguda , Rinosinusitis
15.
Int J Cardiovasc Imaging ; 40(7): 1597-1603, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38613607

RESUMEN

Infective endocarditis (IE) is today a public health problem, as the recent ESC Guidelines have also recalled. Abscesses can be complications of IE and their presence means that the infection is not controlled. We describe the complex case of a 57-year-old patient, presented in ED for fever and oleocranical bursitis, increase of cardiac enymes at blood samples. He was admitted to our Cardiology Unit because TTE showed a floating peduncolated formation in the left ventricle. The susequent TEE documented also the presence of a myocardial abscess, confirmed at cardiac MRI. Blood cultures were positive for MSSA and the man received specific antibiotic therapy. Anticoagulation treatment was started with UFH and then switched to Warfarin, surgical approach of the lesion would have been too dangerous according to Cardiac Surgeons. Serious and sudden neurological complications then followed, leading the patient to brain death in ICU.


Asunto(s)
Absceso , Antibacterianos , Ecocardiografía Transesofágica , Endocarditis Bacteriana , Trombosis , Humanos , Persona de Mediana Edad , Masculino , Absceso/microbiología , Absceso/diagnóstico por imagen , Absceso/tratamiento farmacológico , Antibacterianos/uso terapéutico , Resultado del Tratamiento , Resultado Fatal , Endocarditis Bacteriana/microbiología , Endocarditis Bacteriana/complicaciones , Endocarditis Bacteriana/tratamiento farmacológico , Endocarditis Bacteriana/diagnóstico , Endocarditis Bacteriana/diagnóstico por imagen , Trombosis/diagnóstico por imagen , Trombosis/microbiología , Trombosis/etiología , Trombosis/tratamiento farmacológico , Trombosis/cirugía , Infecciones Estafilocócicas/microbiología , Infecciones Estafilocócicas/tratamiento farmacológico , Infecciones Estafilocócicas/diagnóstico por imagen , Infecciones Estafilocócicas/complicaciones , Infecciones Estafilocócicas/diagnóstico , Anticoagulantes/uso terapéutico , Imagen por Resonancia Magnética
17.
Radiology ; 310(3): e232667, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38501946

RESUMEN

Background Standard-of-care abscess management includes image-guided percutaneous drainage and antibiotics; however, cure rates vary, and concern for antibiotic-resistant bacteria is growing. Photodynamic therapy (PDT), which uses light-activated dyes to generate cytotoxic reactive oxygen species, could complement the standard of care by sterilizing the abscess at the time of drainage. Purpose To evaluate safety and feasibility of PDT with methylene blue (hereafter, MB-PDT) at the time of percutaneous abscess drainage. Materials and Methods This prospective, open-label, dose-escalation, first-in-humans, registered phase 1 clinical study of MB-PDT included participants who underwent percutaneous abdominal or pelvic abscess drainage with CT or US guidance from January 2015 to March 2020 and September 2022 to September 2023. Following drainage, MB-PDT was performed with laser illumination at a fluence rate of 20 mW/cm2, with fluence groups of 6, 12, 18, 24, 30, and 36 J/cm2 (n = 3 each). The primary outcome was safety, indicated by absence of fat embolism, MB escape, abscess wall damage, and need for surgery to remove optical fibers. Preliminary efficacy end points included the time to drainage catheter removal, drainage catheter output volume, and clinical symptom and fever duration. Relationships between fluence and outcomes were analyzed with Spearman correlation and linear regression analyses, and ordinary one-way analysis of variance was used for group comparisons. Results MB-PDT was safe and feasible in all 18 participants (mean age, 60.1 years ± 18.3 [SD]; 10 female), with no negative safety outcomes observed for any participant. No study-related adverse events were encountered, and the procedure did not increase reported pain (P = .1). Clinical symptom and fever duration was shorter in participants receiving higher fluences (30 and 36 J/cm2 vs 6 J/cm2) (P = .03). The presence of antibiotic-resistant bacteria was not predictive of clinical symptom and fever duration (ß = 0.13, P = .37). Conclusion MB-PDT was a safe and feasible adjunct to image-guided percutaneous abscess drainage. Clinical measures indicated a dose-dependent response to PDT. ClinicalTrials.gov registration no.: NCT02240498 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Johnston and Goldberg in this issue.


Asunto(s)
Absceso , Fotoquimioterapia , Femenino , Humanos , Persona de Mediana Edad , Absceso/diagnóstico por imagen , Absceso/tratamiento farmacológico , Antibacterianos , Drenaje , Estudios de Factibilidad , Estudios Prospectivos , Masculino , Adulto , Anciano
18.
World Neurosurg ; 185: e1160-e1168, 2024 05.
Artículo en Inglés | MEDLINE | ID: mdl-38499243

RESUMEN

BACKGROUND: Paravertebral abscess represents a prevalent manifestation of thoracic tuberculosis, often necessitating surgical intervention. In this study, we introduced a novel approach by employing bilateral endoscopic debridement (BED) to address large Paravertebral abscesses associated with thoracic tuberculosis, a method not previously proposed in the literature. The clinical efficacy was examined through a comprehensive 4-year follow-up. METHODS: We conducted a retrospective analysis on patients diagnosed with thoracic tuberculosis and paravertebral abscess who underwent BED combined with local antituberculosis drugs (BED + LAD) between February 2015 and February 2019. A total of 29 eligible patients (12 males and 17 females) with a median (interquartile ranges) of 59.0(16.5) years were included in the study. All patients received the BED + LAD treatment. After the surgery, the patients were treated with a 4-drug antituberculosis therapy (Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol). All relevant indicators were meticulously recorded and analyzed. RESULTS: The surgical procedures were successfully completed for all subjects, with an average intraoperative bleeding volume of (25.2 ± 8.9) ml, an average surgical time of (68.4 ± 14.0) minutes, an average fluoroscopy frequency of (21.7 ± 8.2) times, an average hospital stay of (14.2 ± 4.3) days, and an average medication period of (42.1 ± 9.6) weeks. All subjects completed at least a 4-year follow-up period. At the final follow-up, ESR and CRP levels returned to normal, and there was no significant increase in the Cobb angle (P>0.05). CONCLUSIONS: The application of BED + LAD in the treatment of thoracic tuberculosis and paravertebral abscess proved to be a safe, effective, and feasible approach.


Asunto(s)
Antituberculosos , Desbridamiento , Tuberculosis de la Columna Vertebral , Humanos , Masculino , Femenino , Desbridamiento/métodos , Persona de Mediana Edad , Antituberculosos/uso terapéutico , Antituberculosos/administración & dosificación , Estudios Retrospectivos , Anciano , Estudios de Seguimiento , Adulto , Tuberculosis de la Columna Vertebral/cirugía , Tuberculosis de la Columna Vertebral/tratamiento farmacológico , Tuberculosis de la Columna Vertebral/diagnóstico por imagen , Vértebras Torácicas/cirugía , Vértebras Torácicas/diagnóstico por imagen , Absceso/cirugía , Absceso/tratamiento farmacológico , Resultado del Tratamiento , Terapia Combinada , Neuroendoscopía/métodos
20.
Dermatol Clin ; 42(2): 231-245, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38423684

RESUMEN

Neutrophilic dermatoses are a broadly heterogeneous group of inflammatory skin disorders. This article reviews 5 conditions: amicrobial pustulosis of the folds, aseptic abscess syndrome, Behçet disease, neutrophilic eccrine hidradenitis, and pyostomatitis vegetans-pyodermatitis vegetans.The authors include up-to-date information about their epidemiology, pathogenesis, clinicopathologic features, diagnosis, and management.


Asunto(s)
Síndrome de Behçet , Hidradenitis , Pénfigo , Humanos , Síndrome de Behçet/diagnóstico , Síndrome de Behçet/tratamiento farmacológico , Absceso/diagnóstico , Absceso/tratamiento farmacológico , Piel/patología , Hidradenitis/patología , Compuestos Orgánicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...